Skip to main content
SpringerLink
Log in

Häufige schlafmedizinische Erkrankungen

Frequently occurring sleep disorders

  • Leitthema
  • Published:
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz Aims and scope

Zusammenfassung

Einige Schlafstörungen sind in der Bevölkerung weitverbreitet. Am häufigsten sind das Restless-Legs-Syndrom, die Insomnien und die Schlafapnoen. Diese Schlafstörungen sind inzwischen gut beschrieben und können schnell diagnostiziert und behandelt werden. Da sie Risikofaktoren für kardiovaskuläre, metabolische und psychiatrische Erkrankungen sind, sind die frühe Diagnostik und Therapie zur Prävention dieser Folgen von großer Bedeutung. Die Leistungseinschränkungen durch die Störungen – sei es durch Tagesschläfrigkeit, unterbrochenen Nachtschlaf oder kognitive Defizite – können zu einer erheblichen Minderung der Lebensqualität führen. Die diagnostischen und therapeutischen Empfehlungen wurden aus der S3-Leitlinie „Nicht erholsamer Schlaf/Schlafstörungen“ der Deutschen Gesellschaft für Schlafforschung und Schlafmedizin entnommen. Die Evidenzgrade wurden gemäß des Oxford Centre for Evidence-based Medicine festgelegt.

Abstract

Some sleep disorders are frequently found in the general population. The most common include restless legs syndrome, insomnia, and sleep apnea. These sleep disorders are well classified and can easily be diagnosed and treated. Since they are risk factors for cardiovascular and psychiatric disorders, early diagnosis and treatment are essential to prevent these sequelae. The impairments caused by these sleep disorders (e.g., due to daytime sleepiness, sleep disruption, or cognitive deficits) can result in a significant reduction in a person’s quality of life. The diagnostic and therapeutic recommendations were taken from the S3 guideline “Nonrestorative sleep/sleep disorders” by the German Sleep Society. The levels of evidence were given according to the recommendations of the Oxford Centre for Evidence-based Medicine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. AASM (American Academy of Sleep Medicine) (2005) International classification of sleep disorders, 2. Aufl. ICSD 2 Diagnostic and Coding manual. American Academy of Sleep Medicine, Wechester

  2. Hening W, Walters AS, Allen RP et al (2004) Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med 5:237–246

    Article  PubMed  Google Scholar 

  3. Ohayon M, Reynolds CF 3rd (2009) Epidemiological and clinical relevance of insomnia diagnoses algorithms according to the DSM-IV and the international classification of sleep disorders (ICSD). Sleep Med 10:952–960

    Article  PubMed  Google Scholar 

  4. Young T, Peppard PE, Gottlieb DJ (2002) Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 165:1217–1239

    Article  PubMed  Google Scholar 

  5. Allen R, Picchietti D, Hening W et al (2003) Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institute of Health. Sleep Med 4:101–119

    Article  PubMed  Google Scholar 

  6. Winkelmann J, Schormair B, Lichtner P et al (2007) Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet 39:1000–1006

    Article  PubMed  CAS  Google Scholar 

  7. Allen RP, Earley CJ (2007) The role of iron in restless legs syndrome. Mov Disord 22:S440–S448

    Article  PubMed  Google Scholar 

  8. Trenkwalder C, Benes H, Hornyak M et al (2008) Restless Legs Syndrom (RLS) und Periodic Limb Movement Disorder (PLMD), Leitlinien der Deutschen Gesellschaft für Neurologie. http://www.dgn.org/leitlinien.html

  9. Montplaisir J, Boucher S, Poirier G et al (1997) Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord 12:61–65

    Article  PubMed  CAS  Google Scholar 

  10. Manconi M, Govoni V, De Vito A et al (2004) Restless legs syndrome and pregnancy. Neurology 63:1065–1069

    PubMed  CAS  Google Scholar 

  11. Happe S, Reese JP, Stiasny-Kolster K et al (2009) Assessing health-related quality of life in patients with restless legs syndrome. Sleep Med 10:295–305

    Article  PubMed  Google Scholar 

  12. Lee SJ, Kim JS, Song IU et al (2009) Poststroke restless legs syndrome and lesion location: anatomical considerations. Mov Disord 24:77–84

    Article  PubMed  Google Scholar 

  13. Minai OA, Malik N, Foldvary N et al (2008) Prevalence and characteristics of restless legs syndrome in patients with pulmonary hypertension. J Heart Lung Transplant 27:335–340

    Article  PubMed  Google Scholar 

  14. Ferri R, Zucconi M, Rundo F et al (2007) Heart rate and spectral EEG changes accompanying periodic and non-periodic leg movements during sleep. Clin Neurophysiol 118:438–448

    Article  PubMed  Google Scholar 

  15. Picchietti DL, England SJ, Walters AS et al (1998) Periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder. J Child Neurol 13:588–594

    Article  PubMed  CAS  Google Scholar 

  16. Aukerman MM, Aukerman D, Bayard M et al (2006) Exercise and restless legs syndrome: a randomized controlled trial. J Am Board Fam Med 19:487–493

    Article  PubMed  Google Scholar 

  17. Hornyak M, Kotterba S, Trenkwalder C, Members of the Study Group Motor Disorders of the German Sleep Society (2002) Consensus statement from the German Sleep Society: Indications for performing polysomnography in the diagnosis and treatment of restless leg syndrome. Sleep Med 3(5):457–458

    Article  PubMed  Google Scholar 

  18. Nichols DA, Kushida CA, Allen RP et al (2003) Validation of RLS diagnostic questions in a primary care practice. Sleep 26:A346

    Google Scholar 

  19. Benes H, Kohnen R (2008) Validation of an algorithm for the diagnosis of restless legs syndrome: the restless legs syndrome-index. Sleep Med (doi:10.1016/j.sleep.2008.06.006)

    Google Scholar 

  20. Mayer G, Fietze I, Fischer J et al (2009) S3-Leitlinie nicht erholsamer Schlaf/Schlafstörungen. Somnologie 13(Suppl 1):1–160

    Google Scholar 

  21. Natarajan R (2010) Review of periodic limb movement and restless leg syndrome. J Postgrad Med 56:157–162

    Article  PubMed  CAS  Google Scholar 

  22. Ondo WG, He Y, Rajasekaran S, Le WD (2000) Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: a possible model for restless legs syndrome. Mov Disord 15:154–158

    Article  PubMed  CAS  Google Scholar 

  23. Earley CJ, Connor JR, Beard JL et al (2000) Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology 54:1698–1700

    PubMed  CAS  Google Scholar 

  24. Earley CJ, B Barker P, Horska A, Allen RP (2006) MRI-determined regional brain iron concentrations in early- and late-onset restless legs syndrome. Sleep Med 7:458–461

    Article  PubMed  Google Scholar 

  25. Connor JR, Wang XS, Patton SM et al (2004) Decreased transferrin receptor expression by neuromelanin cells in restless legs syndrome. Neurology 62:1563–1567

    PubMed  CAS  Google Scholar 

  26. Earley CJ, Allen RP, Beard JL, Connor JR (2000) Insight into the pathophysiology of restless legs syndrome. J Neurosci Res 62:623–628

    Article  PubMed  CAS  Google Scholar 

  27. Paulus W, Dowling P, Rijsman R et al (2007) Pathophysiological concepts of restless legs syndrome. Mov Disord 22:1451–1456

    Article  PubMed  Google Scholar 

  28. Hornyak M, Grossmann C, Kohnen R et al (2008) Cognitive behavioural group therapy to improve patients‘ strategies for coping with restless legs syndrome: a proof-of-concept trial. J Neurol Neurosurg Psychiatry 79:823–825

    Article  PubMed  CAS  Google Scholar 

  29. Trenkwalder C, Hening WA, Montagna P et al (2008) Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice. Mov Disord 23(16):2267–2302

    Article  PubMed  Google Scholar 

  30. Garcia-Borreguero D, Allen RP, Benes H et al (2007) Augmentation as a treatment complication of restless legs syndrome: concept and management. Mov Disord 22(Suppl 18):S476–S484

    Article  PubMed  Google Scholar 

  31. Garcia-Borreguero D, Allen RP, Kohnen R et al (2007) Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute. Sleep Med 8:520–530

    Article  PubMed  Google Scholar 

  32. Oertel WH, Stiasny-Kolster K, Bergtholdt B et al (2007) Pramipexole RLS Study Group. Efficacy of pramipexole in restless legs syndrome: a six-week, multicenter, randomized, double-blind study (effect-RLS study). Mov Disord 22:213–219

    Article  PubMed  Google Scholar 

  33. Oertel WH, Benes H, Bodenschatz R et al (2006) Efficacy of cabergoline in restless legs syndrome. Neurology 67:1040–1046

    Article  PubMed  CAS  Google Scholar 

  34. Cornelius JR, Tippmann-Peikert M, Slocumb NL et al (2010) Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study. Sleep 33(1):81–87

    PubMed  Google Scholar 

  35. Alonso J, Vilagut G, Chatterji S et al (2010) Including information about co-morbidity in estimates of disease burden: results from the World Health Organization World Mental Health Surveys. Psychol Med 16:1–142

    Google Scholar 

  36. Ohayon MM (2002) Epidemiology of insomnia: What we know and what we still need to learn. Sleep Med Rev 6:97–111

    Article  PubMed  Google Scholar 

  37. Riemann D, Voderholzer U (2003) Primary insomnia: A risk factor to develop depression? J Affect Disord 76:255–259

    Article  PubMed  Google Scholar 

  38. Suka M, Yoshida K, Sugimori H (2003) Persistent insomnia is a predictor of hypertension in Japanese male workers. J Occup Health 45:344–350

    Article  PubMed  Google Scholar 

  39. Schwartz S, McDowell AW, Cole SR et al (1999) Insomnia and heart disease: a review of epidemiologic studies. J Psychosom Res 47:313–333

    Article  PubMed  CAS  Google Scholar 

  40. Mander B, Colecchia E, Spiegel K et al (2001) Short sleep: a risk factor for insulin resistance and obesity. Diabetes 50:A45

    Google Scholar 

  41. Burgos I, Richter L, Klein T et al (2006) Increased nocturnal Interleukin-6 excretion in patients with primary insomnia: a pilot study. Brain Behav Immun 20:246–253

    Article  PubMed  CAS  Google Scholar 

  42. Althuis MD, Fredman L, Langenberg PW, Magaziner J (1998) The relationship between insomnia and mortality among community-dwelling older women. J Am Geriatr Soc 46:1270–1273

    PubMed  CAS  Google Scholar 

  43. Janson C, Lindberg E, Gislason T et al (2001) Insomnia in men: a 10-year prospective population based study. Sleep 24:425–430

    PubMed  CAS  Google Scholar 

  44. Kripke DF, Garfinkel I, Wingard DL (2002) Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry 59:131–136

    Article  PubMed  Google Scholar 

  45. Liendl S, Lauer CJ, Hoffmann RM (2004) Pre-screening via sleep logs in sleep-disordered patients – adaptational effects, yes or no? Somnologie 8:67–70

    Article  Google Scholar 

  46. Buysse DJ, Ancoli-Israel S, Edinger JD et al (2006) Recommendations for a standard research assessment of insomnia. Sleep 29:1155–1173

    PubMed  Google Scholar 

  47. Riemann D, Voderholzer U, Berger M (2003) Nicht erholsamer Schlaf und Insomnie. Nervenarzt 74:456–469

    Article  Google Scholar 

  48. Benca RM, Obermeyer WH, Thisted RA, Gillin JC (1992) Sleep and psychiatric disorders: a meta-analysis. Arch Gen Psychiatry 49:651–668

    PubMed  CAS  Google Scholar 

  49. Gann H, Calker D van, Feige B, Riemann D (2004) Die Bedeutung des Schlafs für gesunde Alkoholkonsumenten und alkoholabhangige Patienten. Nervenarzt 75:431–441

    Article  PubMed  CAS  Google Scholar 

  50. Kushida CA, Littner MR, Morgenthaler T et al (2005) Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep 28:499–521

    PubMed  Google Scholar 

  51. Riemann D, Spiegelhalder K, Feige B et al (2010) The hyperarousal model of insomnia: a review of the concept and its evidence. Sleep Med Rev 14:19–31

    Article  PubMed  Google Scholar 

  52. Saper CB, Scammell TE, Lu J (2005) Hypothalamic regulation of sleep and circadian rhythms. Nature 437:1257–1263

    Article  PubMed  CAS  Google Scholar 

  53. Lu J, Sherman D, Devor M, Saper CB (2006) A putative flip-flop switch for control of REM sleep. Nature 441:589–594

    Article  PubMed  CAS  Google Scholar 

  54. Winkelman JW, Buxton OM, Jensen E et al (2008) Reduced brain GABA in primary insomnia: preliminary data from 4 T proton magnetic resonance spectroscopy (1 H-MRS). Sleep 31:1499–1506

    PubMed  Google Scholar 

  55. Nofzinger EA, Buysse DJ, Germain A et al (2004) Functional neuroimaging evidence for hyperarousal in insomnia. Am J Psychiatry 161(11):2126–2128

    Article  PubMed  Google Scholar 

  56. Koenigs M, Holliday J, Solomon J, Grafman J (2010) Left dorsomedial frontal brain damage is associated with insomnia. J Neurosci 30(47):16041–16043

    Article  PubMed  CAS  Google Scholar 

  57. Cano G, Mochizuki T, Saper CB (2008) Neural circuitry of stress-induced insomnia in rats. J Neurosci 28:10167–10184

    Article  PubMed  CAS  Google Scholar 

  58. Dauvilliers Y, Morin C, Cervena K et al (2005) Family studies in insomnia. J Psychosom Res 58:271–278

    Article  PubMed  Google Scholar 

  59. Lewy AJ, Ahmed S, Jackson JM et al (1992) Melatonin shifts human circadian rhythms according to a phase-response curve. Chronobiol Int 9:380–392

    Article  PubMed  CAS  Google Scholar 

  60. Chee MWL, Tan JC, Zheng H et al (2008) Lapsing during sleep deprivation is associated with distributed changes in brain activation. J Neurosci 28(21):5519–5528

    Article  PubMed  CAS  Google Scholar 

  61. Hauri PJ (1991) Sleep hygiene, relaxation therapy and cognitive interventions. In: Hauri PJ (Hrsg) Case studies in insomnia. Plenum, NewYork, S 65–84

  62. Means MK, Lichstein KL, Epperson MT, Johnson CT (2000) Relaxation therapy for insomnia: nighttime and daytime effects. Behav Res Ther 38:665–678

    Article  PubMed  CAS  Google Scholar 

  63. Harvey AG, Payne S (2002) The management of unwanted pre-sleep thoughts in insomnia: distraction with imagery vs. general distraction. Behav Res Ther 40:267–277

    Article  PubMed  Google Scholar 

  64. Bootzin RR (1972) A stimulus control treatment for insomnia. In: Proceedings of the 80th Annual Convention of the American Psychological Association. APA, Washington, S 395–396

  65. Spielman AJ, Saskin P, Thorpy MJ (1987) Treatment of chronic insomnia by restriction of time in bed. Sleep 10:45–56

    PubMed  CAS  Google Scholar 

  66. Backhaus J, Riemann D (1999) Schlafstörungen. In: Perlis ML (Hrsg) Fortschritte der Psychotherapie, Bd. VII. Hogrefe, Gottingen

  67. Jungquist C, Smith MT, Posner D (2005) Cognitive behavioural treatment of insomnia – a session-by-session guide. Springer, New York

  68. Duendar Y, Boland J, Strobl J et al (2004a) Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation. Health Technol Assess 8:24–140

    Google Scholar 

  69. Glass J, Lanctot KL, Herrmann N et al (2005) Sedative hypnotics in older people with insomnia: metaanalysis of risks and benefits. BMJ 331:1169–1175

    Article  PubMed  Google Scholar 

  70. Ancoli-Israel S, Richardson GS, Mangano RM (2005) Long-term use of sedative hypnotics in older patients with insomnia. Sleep Med 6:107–113

    Article  PubMed  Google Scholar 

  71. Krystal AD, Erman M, Zammit GK et al (2008) Longterm efficacy and safety of zolpidem extended-release 12,5 mg, administered 3–7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. Sleep 31:79–90

    PubMed  Google Scholar 

  72. Walsh JK, Erman M, Erwin M (1998) Subjective hypnotic efficacy of trazodone and zolpidem in DMSIII-R primary insomnia. Hum Psychopharmacol 13:191–198

    Article  CAS  Google Scholar 

  73. Hajak G, Rodenbeck A, Voderholzer U et al (2001) Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study. J Clin Psychiatry 62(6):453–463

    Article  PubMed  CAS  Google Scholar 

  74. Roth T, Rogowski R, Hull S et al (2007) Efficacy and safety of doxepin 1 mg, 3 mg, an 6 mg in adults with primary insomnia. Sleep 30(11):1555–1561

    PubMed  Google Scholar 

  75. Riemann D, Voderholzer U, Cohrs S et al (2002) Trimipramine in primary insomnia: results of a polysomnographic double-blind placebo and reference-substance (lormetazepam)-controlled study. Pharmacopsychiatry 35:165–174

    Article  PubMed  CAS  Google Scholar 

  76. Jeste DV, Blazer D, Casey D et al (2008) ACNP White Paper: Update on use of antipsychotic drugs in elderly persons with dementia. Neuropsychopharmacol 33:957–970

    Article  CAS  Google Scholar 

  77. Stevinson C, Ernst E (2000) Valerian for insomnia: a systematic review of randomized clinical trials. Sleep Med 1:91–99

    Article  PubMed  Google Scholar 

  78. Bent S, Padula A, Moore D et al (2006) Valerian for sleep: a systematic review and meta-analysis. Am J Med 119:1005–1012

    Article  PubMed  Google Scholar 

  79. Taibi DM, Landis CA, Petry H, Vitiello MV (2007) A systematic review of valerian as a sleep aid: safe but not effective. Sleep Med Rev 11:209–232

    Article  PubMed  Google Scholar 

  80. Wade AG, Ford I, Crawford G et al (2007) Efficacy of prolonged release melatonin in insomnia patients aged 55–80 yrs:quality of sleep and next-day alertness outcomes. Curr Med Res Opin 23(10):2597–2605

    Article  PubMed  CAS  Google Scholar 

  81. Mayer G, Wang-Weigand S, Roth-Schechter B et al (2009) Efficacy and Ssafety of 6-month nightly Ramelteon administration in adults with chronic, primary insomnia. Sleep 32(3):351–360

    PubMed  Google Scholar 

  82. Bradley TD, McNicholas WT, Rutherford R et al (1996) Clinical and physiologic heterogeneity of the central sleep apnea syndrome. Am Rev Respir Dis 134:217–221

    Google Scholar 

  83. Guilleminault C, Robinson A (1996) Central sleep apnea. Neurol Clin 14:611–628

    Article  PubMed  CAS  Google Scholar 

  84. Iber C, Ancoli-Israel S, Chesson A, Quan SF for the American Academy of Sleep Medicine (2007) The AASM Manual for the scoring of sleep and associated events: rules, terminology and technical specifications, 1. Aufl. American Academy of Sleep Medicine, Westchester, Illinois

  85. Marín JM, Carrizo SJ, Vicente E, Agusti AG (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365:1046–1053

    PubMed  Google Scholar 

  86. Gottlieb DJ, Yenokyan G, Newman AB et al (2010) Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation 122(4):352–360

    Article  PubMed  Google Scholar 

  87. Monahan K, Storfer-Isser A, Mehra R et al (2009) Triggering of nocturnal arrhythmias by sleep-disordered breathing events. J Am Coll Cardiol 54(19):1797–1804

    Article  PubMed  Google Scholar 

  88. Garrigue S, Pepin JL, Defaye P et al (2007) High prevalence of sleep apnea syndrome in patients with longterm pacing: the European Multicenter Polysomnographic Study. Circulation 115(13):1703–1709

    Article  PubMed  Google Scholar 

  89. Malhotra A, White DP (2002) Obstructive sleep apnoea. Lancet 360:237–245

    Article  PubMed  Google Scholar 

  90. Ursavas A, Ilcol Y, Nalci N et al (2010) Leptin, adiponectin, and resistin levels in sleep apnea syndrome: role of obesity. Ann Thorac Med 5(3):161–165

    Article  PubMed  CAS  Google Scholar 

  91. Pack AI, Maislin G, Staley B et al (2006) Impaired performance in commercial drivers: role of sleep apnea and short sleep duration. Am J Respir Crit Care Med 174:446–454

    Article  PubMed  Google Scholar 

  92. Meslier N, Gagnadoux F, Giraud P et al (2003) Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome. Eur Respir J 22:156–160

    Article  PubMed  CAS  Google Scholar 

  93. Arias MA, Garcia-Rio F, Alonso-Fernandez A et al (2006) Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure: a randomized, controlled cross-over study. Eur Heart J 27(9):1106–1113

    Article  PubMed  Google Scholar 

  94. Drager LF, Bortolotto LA, Figueiredo AC et al (2007) Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 176(7):706–712

    Article  PubMed  CAS  Google Scholar 

  95. West SD, Nicoll DJ, Stradling JR (2006) Prevalence of obstructive sleep apnoea in men with type 2 diabetes. Thorax 61:945–950

    Article  PubMed  CAS  Google Scholar 

  96. West SD, Nicoll DJ, Wallace TM et al (2007) Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax 62(11):969–974

    Article  PubMed  Google Scholar 

  97. Somers VK, White DP, Amin R et al (2008) Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing, in collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). J Am Coll Cardiol 52(8):686–717

    Article  PubMed  Google Scholar 

  98. Collop NA, Anderson WM, Boehlecke B et al (2007) Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Portable Monitoring Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 3(7):737–747

    PubMed  Google Scholar 

  99. Horner RL (2007) Contributions of passive mechanical loads and active neuromuscular compensation to upper airway collapsibility during sleep. J Appl Phsiol 102:510–512

    Article  Google Scholar 

  100. Zamitt C, Liddicoat H, Moonsie I, Makker H (2010) Obesity and respiratory diseases. Int J Gen Med 3:335–343

    Google Scholar 

  101. Giles TL, Lasserson TJ, Smith B et al (2006) Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 3:CD001106

    PubMed  CAS  Google Scholar 

  102. Durán-Cantolla J, Aizpuru F, Montserrat J-M et al (2010) Continuous positive airway pressure as treatment for systemic hypertension in people with obstructive sleep apnoea: randomised controlled trial. BMJ 341:1–9

    Article  Google Scholar 

  103. Simantirakis EN, Schiza SI, Marketou ME et al (2004) Severe bradyarrhythmias in patients with sleep apnoea: the effect of continuous positive airway pressure treatment: a long-term evaluation using an insertable loop recorder. Eur Heart J 25(12):1070–1076

    Article  PubMed  Google Scholar 

  104. Tregear S, Reston J, Schoelles K, Phillips B (2010) Continuous positive airway pressure reduces risk of motor vehicle crash among drivers with obstructive sleep apnea. Sleep 33(10):1373–1380

    PubMed  Google Scholar 

  105. Kuna ST, Woodson LC, Solanski DR et al (2008) Effect of progressive mandibular advancement on pharyngeal airway size in anesthetized adults. Anesthesiology 109(4):605–612

    Article  PubMed  Google Scholar 

  106. Veasey SC, Guilleminault C, Strohl KP et al (2006) Medical therapy for obstructive sleep apnea: a review by the medical therapy for obstructive sleep apnea task force of the standards of practice committee of the american academy of sleep medicine. Sleep 29(8):1036–1044

    PubMed  Google Scholar 

  107. Brietzke SE, Gallagher D (2006) The effectiveness of tonsillectomy and adenoidectomy in the treatment of pediatric obstructive sleep apnea/hypopnea syndrome: a meta-analysis. Otolaryngol Head Neck Surg 134(6):979–984

    Article  PubMed  Google Scholar 

  108. Kezirian EJ, Goldberg AN (2006) Hypopharyngeal surgery in obstructive sleep apnea: an evidence-based medicine review. Arch Otolaryngol Head Neck Surg 132(2):206–213

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor weist auf folgende Beziehungen hin: Der Autor nimmt an Advisory Boards von UCB und Genzyme teil und hat Vortragshonorare von Cephalon, Sanofi-Aventis, Servier und UCB sowie Forschungsgelder von Cephalon und UCB erhalten.

Author information

Authors and Affiliations

  1. Hephata-Klinik Schwalmstadt-Treysa, Schwalmstadt-Treysa, Deutschland

    G. Mayer

  2. Neurologische Abteilung, Philipps-Universität Marburg, Baldinger Str., 35043, Marburg, Deutschland

    G. Mayer

Authors
  1. G. Mayer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. Mayer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mayer, G. Häufige schlafmedizinische Erkrankungen. Bundesgesundheitsbl. 54, 1284–1295 (2011). https://doi.org/10.1007/s00103-011-1376-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00103-011-1376-0

Schlüsselwörter

Keywords

Search

Navigation